S&P 500   4,305.41 (+0.72%)
DOW   33,683.73 (+0.40%)
QQQ   358.70 (+1.03%)
AAPL   171.10 (+0.39%)
MSFT   314.11 (+0.42%)
META   304.66 (+2.32%)
GOOGL   132.77 (+1.71%)
AMZN   125.85 (-0.10%)
TSLA   245.44 (+2.05%)
NVDA   431.64 (+1.64%)
NIO   8.92 (+5.44%)
BABA   85.49 (-0.81%)
AMD   103.20 (+5.23%)
T   14.91 (+0.27%)
F   12.59 (+1.61%)
MU   65.34 (-4.21%)
CGC   0.83 (-6.88%)
GE   112.48 (+1.43%)
DIS   80.07 (+0.21%)
AMC   7.63 (+0.79%)
PFE   31.96 (-0.44%)
PYPL   58.13 (+1.38%)
NFLX   376.39 (-0.32%)
S&P 500   4,305.41 (+0.72%)
DOW   33,683.73 (+0.40%)
QQQ   358.70 (+1.03%)
AAPL   171.10 (+0.39%)
MSFT   314.11 (+0.42%)
META   304.66 (+2.32%)
GOOGL   132.77 (+1.71%)
AMZN   125.85 (-0.10%)
TSLA   245.44 (+2.05%)
NVDA   431.64 (+1.64%)
NIO   8.92 (+5.44%)
BABA   85.49 (-0.81%)
AMD   103.20 (+5.23%)
T   14.91 (+0.27%)
F   12.59 (+1.61%)
MU   65.34 (-4.21%)
CGC   0.83 (-6.88%)
GE   112.48 (+1.43%)
DIS   80.07 (+0.21%)
AMC   7.63 (+0.79%)
PFE   31.96 (-0.44%)
PYPL   58.13 (+1.38%)
NFLX   376.39 (-0.32%)
S&P 500   4,305.41 (+0.72%)
DOW   33,683.73 (+0.40%)
QQQ   358.70 (+1.03%)
AAPL   171.10 (+0.39%)
MSFT   314.11 (+0.42%)
META   304.66 (+2.32%)
GOOGL   132.77 (+1.71%)
AMZN   125.85 (-0.10%)
TSLA   245.44 (+2.05%)
NVDA   431.64 (+1.64%)
NIO   8.92 (+5.44%)
BABA   85.49 (-0.81%)
AMD   103.20 (+5.23%)
T   14.91 (+0.27%)
F   12.59 (+1.61%)
MU   65.34 (-4.21%)
CGC   0.83 (-6.88%)
GE   112.48 (+1.43%)
DIS   80.07 (+0.21%)
AMC   7.63 (+0.79%)
PFE   31.96 (-0.44%)
PYPL   58.13 (+1.38%)
NFLX   376.39 (-0.32%)
S&P 500   4,305.41 (+0.72%)
DOW   33,683.73 (+0.40%)
QQQ   358.70 (+1.03%)
AAPL   171.10 (+0.39%)
MSFT   314.11 (+0.42%)
META   304.66 (+2.32%)
GOOGL   132.77 (+1.71%)
AMZN   125.85 (-0.10%)
TSLA   245.44 (+2.05%)
NVDA   431.64 (+1.64%)
NIO   8.92 (+5.44%)
BABA   85.49 (-0.81%)
AMD   103.20 (+5.23%)
T   14.91 (+0.27%)
F   12.59 (+1.61%)
MU   65.34 (-4.21%)
CGC   0.83 (-6.88%)
GE   112.48 (+1.43%)
DIS   80.07 (+0.21%)
AMC   7.63 (+0.79%)
PFE   31.96 (-0.44%)
PYPL   58.13 (+1.38%)
NFLX   376.39 (-0.32%)
NASDAQ:YMAB

Y-mAbs Therapeutics (YMAB) Insider Trading & Ownership

$5.57
-0.20 (-3.47%)
(As of 12:52 PM ET)
Compare
Today's Range
$5.38
▼
$5.82
50-Day Range
$4.86
▼
$6.58
52-Week Range
$2.70
▼
$15.89
Volume
91,898 shs
Average Volume
414,200 shs
Market Capitalization
$242.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.63
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Y-mAbs Therapeutics (NASDAQ:YMAB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.50%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$987,670.40
Number Of
Insiders Selling
(Last 12 Months)
0
Get YMAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Y-mAbs Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

YMAB Insider Buying and Selling by Quarter


Y-mAbs Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2023Johan Wedell-WedellsborgDirectorBuy101,740$9.65$981,791.00  
11/15/2022Vignesh RajahCMOBuy1,195$4.92$5,879.40  
(Data available from 1/1/2013 forward)












YMAB Insider Trading Activity - Frequently Asked Questions

Who is on Y-mAbs Therapeutics's Insider Roster?

The list of insiders at Y-mAbs Therapeutics includes Biotech Aps Wg, Bo Kruse, David N Gill, Johan Wedell-Wedellsborg, Pedro Claus Juan Moller-San, Thomas Gad, and Vignesh Rajah. Learn more on insiders at YMAB.

What percentage of Y-mAbs Therapeutics stock is owned by insiders?

21.50% of Y-mAbs Therapeutics stock is owned by insiders. Learn more on YMAB's insider holdings.

Which Y-mAbs Therapeutics insiders have been buying company stock?

The following insiders have purchased YMAB shares in the last 24 months: Johan Wedell-Wedellsborg ($981,791.00), and Vignesh Rajah ($5,879.40).

How much insider buying is happening at Y-mAbs Therapeutics?

Insiders have purchased a total of 102,935 YMAB shares in the last 24 months for a total of $987,670.40 bought.

Which Y-mAbs Therapeutics insiders have been selling company stock?

The following insiders have sold YMAB shares in the last 24 months: Bo Kruse ($593,200.00), and Thomas Gad ($6,164,033.93).

How much insider selling is happening at Y-mAbs Therapeutics?

Insiders have sold a total of 575,626 Y-mAbs Therapeutics shares in the last 24 months for a total of $6,757,233.93 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:YMAB) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -